In Vivo Imaging of Human Neuroinflammation
- 25 March 2016
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 7 (4), 470-483
- https://doi.org/10.1021/acschemneuro.6b00056
Abstract
Neuroinflammation is implicated in the pathophysiology of a growing number of human disorders, including multiple sclerosis, chronic pain, traumatic brain injury, and amyotrophic lateral sclerosis. As a result, interest in the development of novel methods to investigate neuroinflammatory processes, for the purpose of diagnosis, development of new therapies, and treatment monitoring, has surged over the past 15 years. Neuroimaging offers a wide array of non- or minimally invasive techniques to characterize neuroinflammatory processes. The intent of this Review is to provide brief descriptions of currently available neuroimaging methods to image neuroinflammation in the human central nervous system (CNS) in vivo. Specifically, because of the relatively widespread accessibility of equipment for nuclear imaging (positron emission tomography [PET]; single photon emission computed tomography [SPECT]) and magnetic resonance imaging (MRI), we will focus on strategies utilizing these technologies. We first provide a working definition of "neuroinflammation" and then discuss available neuroimaging methods to study human neuroinflammatory processes. Specifically, we will focus on neuroimaging methods that target (1) the activation of CNS immunocompetent cells (e.g. imaging of glial activation with TSPO tracer [(11)C]PBR28), (2) compromised BBB (e.g. identification of MS lesions with gadolinium-enhanced MRI), (3) CNS-infiltration of circulating immune cells (e.g. tracking monocyte infiltration into brain parenchyma with iron oxide nanoparticles and MRI), and (4) pathological consequences of neuroinflammation (e.g. imaging apoptosis with [(99m)Tc]Annexin V or iron accumulation with T2* relaxometry). This Review provides an overview of state-of-the-art techniques for imaging human neuroinflammation which have potential to impact patient care in the foreseeable future.Keywords
Funding Information
- U.S. Department of Health and Human Services (1R21NS087472-01A1)
- U.S. Department of Health and Human Services (T32 5T32EB13180)
- U.S. Department of Defense (W81XWH-14-1-0543)
This publication has 131 references indexed in Scilit:
- Animal Models of Neurological DisordersNeurotherapeutics, 2012
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28Journal of Cerebral Blood Flow & Metabolism, 2011
- Evolution of the blood–brain barrier in newly forming multiple sclerosis lesionsAnnals of Neurology, 2011
- Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cordsNeuroImage, 2011
- Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implicationsBiochimie, 2011
- Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of NeuroinflammationJournal of Cerebral Blood Flow & Metabolism, 2010
- Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine OxidasesBiochemistry, 2009
- Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repairPharmacology & Therapeutics, 2008
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004